AKR1C3 and rheumatoid arthritis: AKR1C3, which has been reported to act as a regulator for hormone activity and prostaglandin F (PGF) synthase associated with promoting the release of inflammatory factors, was found to have a higher expression in the RA group in comparison with HC group (Figure 5A).